Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
Global X Genomics & Biotechnology ETF - USD (GNOM) and Invesco Dynamic Biotechnology & Genome ETF (PBE) belong to the same industry segment: BioTech & Genomics. Both ETFs have the same top 3 sector exposures: and Health Care. GNOM is less expensive with a Total Expense Ratio (TER) of 0.5%, versus 0.58% for PBE. GNOM is down -0.99% year-to-date (YTD) with -$2M in YTD flows. PBE performs worse with -4.59% YTD performance, and +$135K in YTD flows. Run a side-by-side ETF comparison of GNOM and PBE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | GNOM PBE | -2.35%-4.30% | -3.29%-2.36% | -0.99%-4.59% | +29.80%+20.59% | -6.02%+29.95% | -51.80%+5.89% |
| Flows | GNOM PBE | --$3M | -$4M+$969K | -$2M+$135K | -$19M-$32M | -$115M-$56M | +$11M-$39M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | GNOM PBE | +23.45%+18.25% | +30.08%+22.16% | +28.53%+20.15% | +33.47%+22.76% |
| Max drawdown | GNOM PBE | -10.89%-9.23% | -22.14%-16.18% | -46.50%-22.21% | -72.17%-34.74% |
| Max drawdown duration | GNOM PBE | 48d63d | 113d107d | 1031d324d | 1714d1540d |
GNOM | PBE | |
Last sale 3/12/2026 at 1:30 PM | $43.61 | $76.18 |
| Previous close 03/11/2026 | $45.00 | $78.26 |
| Consolidated volume 03/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
GNOM | PBE | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
GNOM | PBE | |
|---|---|---|
| Last price | $43.61 | $76.18 |
| 1D performance | -3.09% | -2.66% |
| AuM | $49.36 M | $247.52 M |
| E/R | 0.5% | 0.58% |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
